Campus

IIT Mandi Researchers Find Potential Method To Reverse Type 2 Diabetes

By
OB Bureau

New Delhi: Union Education Minister Ramesh Pokhriyal Nishank on Saturday congratulated researchers from the Indian Institute of Technology (IIT) Mandi for their discovery of a potential method to reverse type 2 diabetes.

“Diabetes is a common disease in India and this research will help in providing aid to people suffering from the disease. Very proud of IIT Mandi for this innovation,” the minister tweeted.


According to a PTI report, the researchers have found that a drug used to treat opioid addiction can reverse some of the adverse effects of type 2 diabetes.

The team has unravelled the mechanism by which insulin overload in the body causes insulin resistance that is associated with diabetes. The results of the research work, which was funded by the Science and Engineering Research Board (SERB), were recently published in the Journal of Biological Chemistry.

“Insulin, a hormone produced by the pancreas, is used by cells to absorb glucose from the blood. Type 2 diabetes results when cells lose their ability to use insulin due to a variety of reasons. Insulin resistance is intricately linked to a condition called hyperinsulinemia, in which there is excess insulin traversing the bloodstream. The relationship between insulin resistance and hyperinsulinemia is cyclic – each increases the occurrence of the other,” Associate Professor at School of Basic Sciences, IIT Mandi, Prosenjit Mondal, said.

“While it is obvious how insulin resistance leads to hyperinsulinemia — when cells cannot use the insulin, it just remains in the blood — the converse of how hyperinsulinemia increases insulin resistance has hitherto remained unclear. We have known that one of the causes of insulin resistance is inflammation,” he added.

The researchers identified a critical protein molecule, SIRT1, which is repressed in hyperinsulinemia. “The team has found that low dose naltrexone (LDN), a drug commonly administered for opiate addiction, can activate SIRT1, thereby reducing inflammation and increasing insulin sensitivity of cells. The significance of this discovery is enormous,” Mondal said.

Naltrexone is already a Food and Drug Administration-approved drug that is used for the treatment of opioid addiction and can easily be repurposed for inflammation reduction and diabetes control.

OB Bureau

Recent Posts

Waqf Bill, 14 Others Listed For Winter Session Of Parliament

New Delhi: The BJP-led NDA government will introduce 15 bills, including one to amend the…

November 21, 2024

Newborn Sold In Odisha’s Balangir Traced To Raipur Hospital In Chhattisgarh

Bhubaneswar: A newborn baby, who was allegedly sold by her parents in Odisha's Balangir district,…

November 21, 2024

Two More Exit Polls Predict A Mahayuti Win In Maharashtra Elections; Check Here

Mumbai: Exit polls have given Bharatiya Janata Party-led Mahayuti alliance an edge in the neck-to-neck…

November 21, 2024

Orissa HC Issues Interim Stay On Demolition Of Baikuntha Dham Ashram In Bhubaneswar

Cuttack: The Orissa High Court has put the BDA's order for demolition of controversial Shree…

November 21, 2024

Sunita Williams Feasts On Pizza, Roast Chicken & Shrimp Cocktails But Little Fresh Food Left

New York: Amid reports of deteriorating health of astronauts Sunita Williams and Butch Wilmore, it…

November 21, 2024

This Actor Surpasses Shah Rukh Khan, Salman Khan To Become Most Popular Male Film Star

Mumbai: South superstar Prabhas has surpassed Bollywood King Khan Shah Rukh and ‘Dabangg’ Salman Khan…

November 21, 2024

10 Arrested For Attack On BJP MLA Himanshu Sahoo In Odisha’s Jajpur

Jajpur: Police on Thursday arrested 10 persons in connection with the alleged attack on MLA…

November 21, 2024

6 Get Life Term For Raping Woman In Odisha 5 Years Ago

Bhawanipatna: Five year after the rape of a woman, Dharamgarh Additional District and Session court…

November 21, 2024